bf/NASDAQ:LYEL_icon.jpeg

COM:LYELL

Lyell Immunopharma, Inc.

  • Stock

Last Close

0.92

22/11 21:00

Market Cap

402.80M

Beta: -

Volume Today

1.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
account payables
2.84M
-
9.40M
230.38%
3.21M
65.87%
3.92M
22.14%
4.82M
22.98%
accumulated other comprehensive income loss
454K
-
256K
43.61%
-1.62M
733.98%
-7.60M
368.21%
-94K
98.76%
cash and cash equivalents
96.67M
-
140.41M
45.24%
293.83M
109.27%
123.55M
57.95%
145.65M
17.88%
cash and short term investments
436.05M
-
612.62M
40.49%
614.79M
0.36%
640.15M
4.12%
546.22M
14.67%
common stock
1K
-
2K
100%
24K
1,100%
25K
4.17%
25K
0%
deferred revenue
4.51M
-
6.09M
35.11%
4.99M
18.16%
21.87M
338.43%
20.36M
6.90%
deferred revenue non current
98.41M
-
89.07M
9.49%
79.67M
10.56%
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt
27.13M
-
50.96M
87.86%
66.65M
30.80%
63.17M
5.22%
56.89M
9.93%
long term investments
68.98M
-
163.44M
136.93%
330.53M
102.23%
115.04M
65.20%
48.51M
57.84%
net debt
-69.20M
-
-85.83M
24.03%
-226.01M
163.32%
-55.85M
75.29%
-82.48M
47.68%
net receivables
other assets
other current assets
4.21M
-
4.93M
17.05%
11.49M
133.20%
11.14M
3.04%
8.46M
24.05%
other current liabilities
14.35M
-
30.18M
110.35%
37.37M
23.85%
6.71M
82.05%
3.07M
54.25%
other liabilities
other non current assets
2.68M
-
3.23M
20.53%
3.95M
22.07%
4.96M
25.60%
4.52M
8.89%
other non current liabilities
532K
-
4.57M
758.27%
4.11M
9.92%
3.66M
10.92%
othertotal stockholders equity
18.11M
-
41.36M
128.39%
388.34M
839.00%
1.61B
314.15%
1.66B
3.04%
preferred stock
519.16M
-
1.01B
94.73%
1.13B
11.52%
property plant equipment net
43.70M
-
124.06M
183.85%
166.64M
34.33%
166.26M
0.22%
142.32M
14.40%
retained earnings
-129.67M
-
-334.14M
157.69%
-584.36M
74.88%
-767.48M
31.34%
-1.00B
30.57%
short term debt
344K
-
3.62M
951.45%
1.17M
67.68%
4.53M
287.85%
6.27M
38.35%
short term investments
339.38M
-
472.21M
39.14%
320.97M
32.03%
516.60M
60.95%
400.58M
22.46%
tax assets
tax payables
total assets
555.63M
-
908.28M
63.47%
1.13B
24.13%
937.56M
16.84%
750.03M
20.00%
total current assets
440.26M
-
617.55M
40.27%
626.29M
1.42%
651.29M
3.99%
554.69M
14.83%
total current liabilities
22.05M
-
49.28M
123.57%
46.74M
5.17%
37.03M
20.78%
34.52M
6.78%
total debt
27.47M
-
54.57M
98.67%
67.82M
24.27%
67.70M
0.17%
63.17M
6.70%
total investments
408.36M
-
635.66M
55.66%
651.50M
2.49%
631.64M
3.05%
449.08M
28.90%
total liabilities
147.58M
-
189.84M
28.64%
197.62M
4.10%
104.31M
47.22%
95.08M
8.85%
total liabilities and stockholders equity
555.63M
-
908.28M
63.47%
1.13B
24.13%
937.56M
16.84%
750.03M
20.00%
total non current assets
115.37M
-
290.73M
152.00%
501.12M
72.36%
286.27M
42.87%
195.34M
31.76%
total non current liabilities
125.53M
-
140.56M
11.97%
150.88M
7.35%
67.28M
55.41%
60.56M
9.99%
total stockholders equity
408.06M
-
718.44M
76.06%
929.79M
29.42%
833.25M
10.38%
654.95M
21.40%

All numbers in (except ratios and percentages)